Literature DB >> 22009320

Position 45 influences the peptide binding motif of HLA-B*44:08.

Soumya Badrinath1, Trevor Huyton, Heike Schumacher, Rainer Blasczyk, Christina Bade-Doeding.   

Abstract

Position 45 represents a highly polymorphic residue within HLA class I alleles, which contacts the p2 position of bound peptides in 85% of the peptide-HLA structures analyzed, while the neighboring residues 41 and 46 are not involved in peptide binding. To investigate the influence of residue 45 at the functional level, we sequenced peptides eluted from recombinant HLA-B*44:08(41Ala/45Met/46Ala) molecules and compared their features with known peptides from B*44:02(41Thr/45Lys/46Glu). While HLA-B*44:02 has an anchor motif of E at the p2 anchor position, HLA-B*44:08 exhibits Q and L as anchor motif. The 45(Met/Lys) polymorphism contributes to the alteration in the peptide-binding motif and provides further evidence that mismatches at position 45 should be considered as nonpermissive in a transplantation setting.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009320     DOI: 10.1007/s00251-011-0583-z

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  20 in total

1.  HLA-B15 peptide ligands are preferentially anchored at their C termini.

Authors:  K R Prilliman; K W Jackson; M Lindsey; J Wang; D Crawford; W H Hildebrand
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

2.  Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype.

Authors:  Nina Hillen; Gabor Mester; Claudia Lemmel; Andreas O Weinzierl; Margret Müller; Dorothee Wernet; Jörg Hennenlotter; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

3.  MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming.

Authors:  M Hirosawa; M Hoshida; M Ishikawa; T Toya
Journal:  Comput Appl Biosci       Date:  1993-04

Review 4.  A general overview of the status of bone marrow transplantation for hematologic diseases.

Authors:  K G Blume
Journal:  Leukemia       Date:  1993-07       Impact factor: 11.528

Review 5.  History, current results, and research in marrow transplantation.

Authors:  E D Thomas
Journal:  Perspect Biol Med       Date:  1995       Impact factor: 1.416

6.  Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants.

Authors:  Christina Bade-Doeding; David S DeLuca; Axel Seltsam; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  Immunogenetics       Date:  2007-02-10       Impact factor: 2.846

Review 7.  Optimal HLA matching in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf
Journal:  Curr Opin Immunol       Date:  2008-08-08       Impact factor: 7.486

Review 8.  High-dose therapy and bone marrow transplantation.

Authors:  E D Thomas
Journal:  Semin Oncol       Date:  1985-12       Impact factor: 4.929

9.  HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.

Authors:  C A Keever; N Leong; I Cunningham; E A Copelan; B R Avalos; J Klein; N Kapoor; P W Adams; C G Orosz; P J Tutschka
Journal:  Bone Marrow Transplant       Date:  1994-07       Impact factor: 5.483

10.  HLA class I molecules reflect an altered host proteome after influenza virus infection.

Authors:  Angela Wahl; Fredda Schafer; Wilfried Bardet; William H Hildebrand
Journal:  Hum Immunol       Date:  2010-01       Impact factor: 2.850

View more
  6 in total

1.  Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09.

Authors:  Trevor Huyton; Heike Schumacher; Rainer Blasczyk; Christina Bade-Doeding
Journal:  Immunogenetics       Date:  2012-06-16       Impact factor: 2.846

2.  A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Authors:  F David Carmona; Sarah L Mackie; Jose-Ezequiel Martín; John C Taylor; Augusto Vaglio; Stephen Eyre; Lara Bossini-Castillo; Santos Castañeda; Maria C Cid; José Hernández-Rodríguez; Sergio Prieto-González; Roser Solans; Marc Ramentol-Sintas; M Francisca González-Escribano; Lourdes Ortiz-Fernández; Inmaculada C Morado; Javier Narváez; José A Miranda-Filloy; Lorenzo Beretta; Claudio Lunardi; Marco A Cimmino; Davide Gianfreda; Daniele Santilli; Giuseppe A Ramirez; Alessandra Soriano; Francesco Muratore; Giulia Pazzola; Olga Addimanda; Cisca Wijmenga; Torsten Witte; Jan H Schirmer; Frank Moosig; Verena Schönau; Andre Franke; Øyvind Palm; Øyvind Molberg; Andreas P Diamantopoulos; Simon Carette; David Cuthbertson; Lindsy J Forbess; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry Moreland; Paul A Monach; Christian Pagnoux; Philip Seo; Robert Spiera; Antoine G Sreih; Kenneth J Warrington; Steven R Ytterberg; Peter K Gregersen; Colin T Pease; Andrew Gough; Michael Green; Lesley Hordon; Stephen Jarrett; Richard Watts; Sarah Levy; Yusuf Patel; Sanjeet Kamath; Bhaskar Dasgupta; Jane Worthington; Bobby P C Koeleman; Paul I W de Bakker; Jennifer H Barrett; Carlo Salvarani; Peter A Merkel; Miguel A González-Gay; Ann W Morgan; Javier Martín
Journal:  Am J Hum Genet       Date:  2015-03-26       Impact factor: 11.025

3.  A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes.

Authors:  Soumya Badrinath; Heike Kunze-Schumacher; Rainer Blasczyk; Trevor Huyton; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-12-04       Impact factor: 4.818

4.  Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches.

Authors:  Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-09-01       Impact factor: 4.818

5.  HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome.

Authors:  Thomas Kraemer; Alexander A Celik; Trevor Huyton; Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Döding
Journal:  Stem Cells Int       Date:  2015-08-12       Impact factor: 5.443

6.  The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch.

Authors:  Alexander A Celik; Thomas Kraemer; Trevor Huyton; Rainer Blasczyk; Christina Bade-Döding
Journal:  Immunogenetics       Date:  2015-11-09       Impact factor: 2.846

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.